Scarica l'app Stockscreener
6.4431
6.15%
0.3731
Precedente Chiudi:
$6.07
Aprire:
$6.18
Volume 24 ore:
1,437
Relative Volume:
0.12
Capitalizzazione di mercato:
$20.98M
Reddito:
$1.18B
Utile/perdita netta:
$-126.34M
Rapporto P/E:
-0.00285
EPS:
-2260.66
Flusso di cassa netto:
$-94.09M
1 W Prestazione:
+3.09%
1M Prestazione:
-11.25%
6M Prestazione:
-35.57%
1 anno Prestazione:
-77.22%
Intervallo 1D:
$6.16
$6.18
Intervallo di 1 settimana:
$6.00
$6.4512
Portata 52W:
$6.00
$32.54
P 3 Health Partners Inc Stock (PIII) Company Profile
Nome
P 3 Health Partners Inc
Settore
Industria
Telefono
312-822-8897
Indirizzo
2045 W GRAND AVE STE B, CHICAGO
Confronta PIII con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PIII
P 3 Health Partners Inc
|
6.16 | 20.98M | 1.18B | -126.34M | -94.09M | -2,260.66 |
|
HCA
Hca Healthcare Inc
|
381.98 | 87.79B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
28.19 | 16.81B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
175.41 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
122.18 | 12.02B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
180.80 | 11.13B | 16.08B | 1.20B | 1.06B | 17.82 |
P 3 Health Partners Inc Stock (PIII) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-09-01 | Iniziato | BTIG Research | Buy |
| 2023-06-30 | Iniziato | TD Cowen | Market Perform |
P 3 Health Partners Inc Borsa (PIII) Ultime notizie
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc. - GlobeNewswire
Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now - sharewise
P3 Health Partners’ Shareholders Approve Key Proposals - TipRanks
PIIIP3 Health Partners Announces Third Quarter 2024 Results - mx.advfn.com
P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction - mx.advfn.com
UnitedHealth woes incite worry about its value-based partners - Modern Healthcare
P3 Health Partners (NASDAQ:PIII) Stock Price Down 3.4% – Should You Sell? - Defense World
p3 health partners enters financing agreement with vbc growth spv 5 - Investing.com
P3 Health Partners Secures $70M Financing Deal - TipRanks
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc. - GlobeNewswire Inc.
P3 Health Partners price target lowered to $8 from $12.50 at TD Cowen - Yahoo Finance
P3 Health Partners (PIII) Price Target Cut by TD Cowen | PIII Stock News - GuruFocus
Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII) - Yahoo Finance
Ardent Health Partners, Inc. Updates Name to Ardent Health, Inc. - Business Wire
Form 8.3Primary Health Properties plc - Business Wire
P3 Health Partners reaffirms $130M EBITDA improvement plan as operational initiatives accelerate in 2025 - MSN
P3 Health Partners Inc. (NASDAQ:PIII) Q1 2025 Earnings Call Transcript - Insider Monkey
P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
P3 Health Partners’ Earnings Call: Strategic Gains Amid Challenges - TipRanks
Earnings call transcript: P3 Health Partners Q1 2025 revenue falls short - Investing.com
P3 Health Partners Reports Q1 2025 Financial Results - TipRanks
Transcript : P3 Health Partners Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
P3 Health Partners Q1 2025 Earnings Call Transcript - MarketBeat
P3 Health Partners (PIII) Exceeds Q1 Revenue Expectations with Strategic Advancements | PIII Stock News - GuruFocus
P3 Health Partners reports Q1 EPS ($6.28) vs ($7.86) last year - TipRanks
P3 Health Partners Announces First Quarter 2025 Results - marketscreener.com
Cybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorder - Business Wire
Valley Health Partners Celebrates Opening of Comprehensive Healthcare Center in Easton’s South Side - The Valley Ledger
What to Expect from P3 Health Partners's Earnings - Nasdaq
P3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance
P3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: W - GuruFocus
P3 Media Named Shopify Platinum Partner, Recognized Among Top 1% of Agencies Worldwide - Yahoo Finance
P3 Health Partners (PIII) to Release Earnings on Thursday - Defense World
P3 Health Partners (NASDAQ:PIII) Stock Price Down 3% – Here’s What Happened - Defense World
Elizabeth Holmes' partner raises millions for new biotech testing startup - NPR
Jacmel Partners Announces P3 Investment in New York's LaGuardia Airport Terminal B - Yahoo Finance
P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call - Business Wire
PAQ Therapeutics Announces $39 Million Series B Financing and Initiates Phase 1 Trial to Advance Novel Approach Addressing KRAS-Driven Cancers with High Unmet Need - Yahoo Finance
Apotex announces expansion of licensing agreement with Formosa Pharmaceuticals to Mexico for commercialization of clobetasol propionate ophthalmic suspension for the treatment of inflammation and pain following ocular surgery - Yahoo Finance
Clackamas Progress Partners announces completion of Oregon’s first P3 courthouse - Yahoo Finance
P3 Health Partners Inc expected to post a loss of $8.91 a shareEarnings Preview - TradingView
Kavira Health Partners With Building Industry Health Plan of the Red River Valley to Expand Into Fargo, North Dakota - Yahoo Finance
New Interdisciplinary Partnership Between Nursing and World Languages - Southwestern Oklahoma State University | SWOSU
P3 Health Partners (NASDAQ:PIII) Price Target Lowered to $20.00 at Lake Street Capital - Defense World
P 3 Health Partners Inc Azioni (PIII) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
P 3 Health Partners Inc Azioni (PIII) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chicago Pacific Founders UGP I | 10% Owner |
Sep 13 '24 |
Buy |
0.50 |
80,000 |
39,952 |
77,185,438 |
| Chicago Pacific Founders UGP I | 10% Owner |
Sep 11 '24 |
Buy |
0.56 |
80,000 |
44,728 |
77,025,438 |
| Chicago Pacific Founders UGP I | 10% Owner |
Sep 09 '24 |
Buy |
0.53 |
80,000 |
42,672 |
76,865,438 |
| Chicago Pacific Founders UGP I | 10% Owner |
Sep 10 '24 |
Buy |
0.52 |
80,000 |
41,224 |
76,945,438 |
| Chicago Pacific Founders UGP I | 10% Owner |
Sep 05 '24 |
Buy |
0.49 |
80,000 |
39,296 |
76,705,438 |
| Chicago Pacific Founders UGP I | 10% Owner |
Sep 06 '24 |
Buy |
0.49 |
80,000 |
39,184 |
76,785,438 |
| Chicago Pacific Founders UGP I | 10% Owner |
Sep 04 '24 |
Buy |
0.49 |
80,000 |
39,064 |
76,625,438 |
0.09%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):